779 related articles for article (PubMed ID: 24504799)
1. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
2. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
3. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound IL-6R is upregulated on Th17 cells and inhibits Treg cell migration by regulating post-translational modification of VASP in autoimmune arthritis.
Yan S; Golumba-Nagy V; Kotschenreuther K; Thiele J; Refaian N; Shuya D; Gloyer L; Dittrich-Salamon M; Meyer A; Heindl LM; Kofler DM
Cell Mol Life Sci; 2021 Dec; 79(1):3. PubMed ID: 34913099
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction.
Moon SJ; Park JS; Woo YJ; Lim MA; Kim SM; Lee SY; Kim EK; Lee HJ; Lee WS; Park SH; Jeong JH; Park SH; Kim HY; Cho ML; Min JK
Arthritis Rheumatol; 2014 Apr; 66(4):874-85. PubMed ID: 24757140
[TBL] [Abstract][Full Text] [Related]
8. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
[TBL] [Abstract][Full Text] [Related]
9. STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis.
Park JS; Kwok SK; Lim MA; Kim EK; Ryu JG; Kim SM; Oh HJ; Ju JH; Park SH; Kim HY; Cho ML
Arthritis Rheumatol; 2014 Apr; 66(4):918-29. PubMed ID: 24757144
[TBL] [Abstract][Full Text] [Related]
10. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
11. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice.
Thiolat A; Denys A; Petit M; Biton J; Lemeiter D; Herve R; Lutomski D; Boissier MC; Bessis N
Cytokine; 2014 Sep; 69(1):87-93. PubMed ID: 25022966
[TBL] [Abstract][Full Text] [Related]
14. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
Chen L; Wu X; Zhong J; Li D
BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
[TBL] [Abstract][Full Text] [Related]
15. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis.
Hui W; Yu D; Cao Z; Zhao X
Int Immunopharmacol; 2019 Mar; 68():226-233. PubMed ID: 30660077
[TBL] [Abstract][Full Text] [Related]
16. Dual-specificity phosphatase 5 attenuates autoimmune arthritis in mice via reciprocal regulation of the Th17/Treg cell balance and inhibition of osteoclastogenesis.
Moon SJ; Lim MA; Park JS; Byun JK; Kim SM; Park MK; Kim EK; Moon YM; Min JK; Ahn SM; Park SH; Cho ML
Arthritis Rheumatol; 2014 Nov; 66(11):3083-95. PubMed ID: 25047518
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab treatment leads to a rapid and sustained increase in Treg cell levels in rheumatoid arthritis patients: comment on the article by Thiolat et al.
Sarantopoulos A; Tselios K; Gkougkourelas I; Pantoura M; Georgiadou AM; Boura P
Arthritis Rheumatol; 2014 Sep; 66(9):2638. PubMed ID: 24891239
[No Abstract] [Full Text] [Related]
18. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
Schinnerling K; Aguillón JC; Catalán D; Soto L
Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
[TBL] [Abstract][Full Text] [Related]
19. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
[TBL] [Abstract][Full Text] [Related]
20. Does tocilizumab indeed reduce the frequency of Th17 cells? Comment on the article by Thiolat et al.
Samson M; Audia S; Ornetti P; Maillefert JF; Janikashvili N; Bonnotte B
Arthritis Rheumatol; 2014 Sep; 66(9):2639-40. PubMed ID: 24891312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
